Cited by 878Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

Seeman, P., Lee, T.·1975·Science

DOI 10.1126/science.1145194

Open this paper in CoChat — free account

Abstract

Neuroleptic (antipsychotic) drugs inhibited the electrically stimulated release of [3 H]dopamine from rat striatal slices. The concentrations for 50 percent inhibition (ranging from 11.5 nanomolar for spiroperidol to 800 nanomolar for thioridazine) correlated closely with the average daily dosages of 25 neuroleptic drugs used clinically for schizophrenia. The correlation includes butyrophenones, phenothiazines, reserpine, pimozide, clozapine, and (+)-butaclamol. Clinically inactive isomers [trans-thiothixene,trans-flupenthixol, and (-)-butaclamol] required 20 to 1000 times higher concentrations than the active isomers to inhibit release. Compared to the inhibition of [3 H]dopamine release, much higher neuroleptic concentrations were needed to inhibit the electrically stimulated release of other neurotransmitters—[3 H]acetylcholine, [3 H]GABA (γ-aminobutyric acid). The neuroleptic drugs may block the presynaptic coupling between impulse and neurosecretion.

Integrity signals

Registry

Crossref · 10.1126/science.1145194

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Membrane Actions of Anesthetics and Tranquilizers
Seeman, P. M. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06931-5 · Cited by 2,241
Self-citation
Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,156
DOPAMINERGIC NEURONS: EFFECT OF ANTIPSYCHOTIC DRUGS AND AMPHETAMINE ON SINGLE CELL ACTIVITY
Bunney, B. S., Walters, J. R., Roth, R. H., & Aghajanian, G. K. (1973) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29539-8 · Cited by 1,283
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
Andén, N., Butcher, S. G., CORRODI, H., Fuxé, K., & Ungerstedt, U. (1970) · European Journal of Pharmacology · doi:10.1016/0014-2999(70)90006-3 · Cited by 1,026
Drugs, Neurotransmitters, and Schizophrenia
Snyder, S. H., Banerjee, S. P., Yamamura, H. I., & Greenberg, D. A. (1974) · Science · doi:10.1126/science.184.4143.1243 · Cited by 834
The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs.
Jm, V. R. (1966) · PubMed · Cited by 508
Dopamine-Sensitive Adenylate Cyclase in Mammalian Brain: A Possible Site of Action of Antipsychotic Drugs
Clement‐Cormier, Y. C., Kebabian, J. W., Petzold, G. L., & Greengard, P. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1113 · Cited by 452
Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., & Atack, C. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb09104.x · Cited by 417
IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.
Janssen, P. A., Cj, N., & Schellekens, K. H. L. (1965) · PubMed · Cited by 348
Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
Matthysse, S. (1973) · PubMed · Cited by 338

Show all 35 references

Research works printed but not linked: 9

Aghajanian, G. K., Frontiers in Neurology and Neuroscience Research: 4 (1974).
FARNEBO, L. O., ACTA PHYSIOLOGICA SCANDINAVICA 371: 19 (1971).
FARNEBO, L. O., ACTA PHYSIOLOGICA SCANDINAVICA 371: 35 (1971).
Munkvad, I., The Neuroleptics. Modern Problems in Pharmacopsychiatrv 5: 44 (1970).
RITCHIE, J.M., ON ACTIVE STRUCTURE OF LOCAL ANESTHETICS, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 133: 241 (1961).
SEEMAN, P, FEDERATION PROCEEDINGS 33: 246 (1974).
SOTELO, C, ULTRASTRUCTURAL IDENTIFICATION OF NIGRAL DOPAMINERGIC CELLS IN RAT, JOURNAL DE PHARMACOLOGIE 5: 55 (1974).
STAWARZ, R.J., SIGNIFICANCE OF INCREASE OF HOMOVANILLIC-ACID (HVA) CAUSED BY ANTIPSYCHOTICS IN CORPUS STRIATUM AND LIMBIC FOREBRAIN, FEDERATION PROCEEDINGS 33: 246 (1974).
ZIVKOVIC, B, SPECIFIC ACTIVATION OF STRIATAL TYROSINE-HYDROXYLASE (TH) BY NEUROLEPTICS, FEDERATION PROCEEDINGS 33: 536 (1974).

Sorted by citations

Items 701–800 of 878

Anti-schizophrenic Drugs: Membrane Receptor Sites of Action
Seeman, P. M., Tedesco, J., Titeler, M., & Hartley, E. J. (1979) · Elsevier eBooks · doi:10.1016/b978-0-08-023195-2.50005-0 · Cited by 2
Self-citation
Unraveling the role of Slc10a4 in auditory processing and sensory motor gating: Implications for neuropsychiatric disorders?
Ciralli, B., Malfatti, T., Hilscher, M. M., Leão, R. N., Cederroth, C. R., Leão, K. E., & Kullander, K. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110930 · Cited by 1
Pharmacological Activity of Scopoletin: Deciphering the Potential of Coumarins in Cognitive Dysfunction
Wal, P., Vadera, S., Aziz, N., Gupta, P., Rajesh, K. S., Rao, C. M. P., & Sharma, M. C. (2025) · Current Drug Research Reviews · doi:10.2174/0125899775358899250726213130 · Cited by 1
A neuroimmune framework for understanding adolescent stress and risk of alcohol misuse
Aeschlimann, L., Bouzourène, N., Rossetti, C., & Boutrel, B. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101242 · Cited by 1
“…catalyzed by molecular discoveries: opioid receptors (Pert and Snyder, 1973), endogenous opioids (Hughes et al., 1975) (building on conceptual work of Goldstein et al., 1971) and dopamine receptors (Seeman and Lee, 1975; Burt et al., 1975), solidifying addiction's neurochemical underpinnings.”
Eye movements and schizophrenia risk genes. Associations of the putative schizophrenia risk genes COMT and NRG-1 with smooth pursuit and antisaccade eye movement endophenotypes in schizophrenia patients and healthy controls drawn from the homogenous Icelandic population
Haraldsson, M. H. (2010) · Cited by 1
Studies of the Dopamine Hypothesis of Schizophrenia
Sternberg, D. E., & Extein, I. (1985) · Elsevier eBooks · doi:10.1016/b978-0-409-95184-4.50020-5 · Cited by 1
The possible role of beta-adrenergic and alpha-adrenergic antagonist sensitive systems in the brain in the mechanism of psychosis
Blum, I., & Atsmon, A. (1976) · Medical Hypotheses · doi:10.1016/0306-9877(76)90053-0 · Cited by 1
Differential sensitivity of the Brattleboro rat to glutamatergic and dopaminergic perturbation
Lin, R. E., Suh, J., Ambler, L., Billingslea, E. N., Cho, M., Ciacci, A., Tatard-Leitman, V. M., Featherstone, R. E., & Siegel, S. J. (2014) · Journal of Psychiatry and Brain Functions · doi:10.7243/2055-3447-1-3
“Further clinical studies provide evidence that the effective dose of antipsychotic drugs is related to their affinity to dopamine type 2 receptors [11-14].”
Background
Pharmacological Models of Psychosis - Amphetamine and Ketamine
Chan, S. K. W. (2011) · The HKU Scholars Hub (University of Hong Kong) · Cited by 1
Serotonin 5-HT2B receptor antagonism is fundamental for protecting PC12 cells exposed to hydrogen peroxide
Takayanagi, T., Yoko Kaneko, S., Nagasaki, H., Kodani, Y., Nakashima, A., Mori, K., Suzuki, A., Itoh, M., Kondo, K., Nagatsu, T., et al. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.20407/fmj.1.1_1 · Cited by 1
DataBrain: a web-accessible database for three-dimensional reconstructions and quantitative morphometrics of neurons
Magliaro, C., Callara, A. L., Arami, N., Maria, C. D., Ferrari, V., Vanello, N., Tognetti, A., Mangione, M., Viaggi, M. C., Vaglini, F., et al. (2017) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-981-10-5122-7_192 · Cited by 1
Models of Schizophrenia. A Selective Review of Genetic, Neuropharmacological, Cognitive, and Social Approaches
Ichinose, M. C., & Park, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815012-2.00002-x · Cited by 1
Mental Health Retrosight: Case studies
Pollitt, A., Diepeveen, S., Guthrie, S., Morgan Jones, M., Ni Chonaill, S., Olmsted, S. S., Schultz, D., Pincus, H. A., Grant, J., & Wooding, S. (2013) · RAND Corporation eBooks · doi:10.7249/rr452 · Cited by 1
Schizophrenia
Marino, M. J., Davis, R. E., Meltzer, H. M., Knutsen, L. J. S., & Williams, M. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00162-0 · Cited by 1
Solving the New Puzzle(s) 2014-2022: Flammer Syndrome Probably Represents a Mild Endophenotype of Raynaud’s Phenomenon Mainly Associated with Ocular Disturbances and Also Due to Latent T. gondii Infection
PRANDOTA, J. (2023) · Journal of Clinical Medicine Current Research · doi:10.53043/2832-7551.jcmcr.3.007 · Cited by 2
Action of Antipsychotics
Gangadhar, B. N., & Rao, N. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00115-9 · Cited by 1
Dopamine and the Biology and Course of Treatment Resistance
Demjaha, A., & Howes, O. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-45257-4_3 · Cited by 1
A Brief Guide to Medications for Psychosis
Harris, A. W. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815012-2.00023-7 · Cited by 1
Depression and Other Forms of Mental Illness
Freed, W. J. (2022) · Springer eBooks · doi:10.1007/978-3-031-10477-0_19 · Cited by 1
Proceedings:Pre- and postsynaptic actions of neuroleptic drugs.
Iversen, L. L., Miller, R. J., & Rogawski, M. A. (1975) · PubMed Central · Cited by 1
Tempo de resposta a tratamento antipsicótico na esquizofrenia de início recente: um estudo randomizado e controlado de 12 semanas
Kayo, M. (2010) · doi:10.11606/d.5.2010.tde-01022011-175641 · Cited by 1
Molecular Mechanism of the Involvement of the Susceptibility Genes, DISC1, PACAP, TRAP1 and Dysbindin in Major Psychiatric Disorders Such as Schizophrenia, Depression and Bipolar Disease
Katayama, T., Matsuzaki, S., Hattori, T., & Tohyam, M. (2011) · InTech eBooks · doi:10.5772/26905 · Cited by 1
Influenza A virus infection and NMDA receptor function : A behavioral and molecular study of relevance for schizophrenia
Beraki, S. (2008) · Figshare · Cited by 1
EFFECT OF INTRACEREBROVENTRICULAR ADMINISTRATION OF CHLORPROMAZINE ON THE SERUM LEVEL OF FREE FATTY ACIDS IN RATS
Uchida, Y., & Nomoto, T. (1982) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)52649-x · Cited by 1
Significance of neurochemical parameters in the preclinical evaluation of neuroleptic drugs
Cattabeni, F., Galli, C. L., Groppetti, A., & Racagni, G. (1979) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(79)90131-1 · Cited by 1
Studies of chlorpromazine-induced enhancement of the potentials evoked by peripheral stimulation of the cat cerebellum.
Hagiwara, Y., & Suzuki, Y. (1987) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.44.323 · Cited by 1
Short and long-term effects of neuroleptics in relation to their cellular mechanism of action
Stefanis, C., & Issidorides, M. R. (1979) · Progress in Neuro-Psychopharmacology · doi:10.1016/0364-7722(79)90089-4 · Cited by 1
Catecholamine Precursors Improve Psychophysical Activity
Tajima, Y., & Nakagawa, R. (1999) · Clinical Drug Investigation · doi:10.2165/00044011-199918040-00009 · Cited by 1
Psychotropic drugs and taxonomic systems
Shepherd, M. (1980) · Psychological Medicine · doi:10.1017/s0033291700039581 · Cited by 1
Finding Genes Underlying Schizophrenia Retinoid and Thyroid Hormone Hypotheses
Neto, D. R. (2007) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Selected genetic polymorphisms of epidermal growth factor, dopamine-2 receptor, neuregulin-1 and inflammatory cytokines in schizophrenia
Hänninen, K. (2014) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Encoding of Temporal Sound Features in the Rodent Superior Paraolivary Nucleus
Felix, R. A. (2011) · doi:10.33915/etd.3396
“Acepromazine inhibits dopaminergic receptors (Feinberg and Snyder, 1975; Seeman and Lee 1975), and is recommended at a dosage of 1.”
Background
EFFECTS OF PSYCHOTROPIC DRUGSCOMBINED WITH d-AMPHETAMINEON SIDMAN AVOIDANCE RESPONSE IN RATS
Kuribara, H., & Tadokoro, S. (1980) · Kitakantou igaku/Kitakantō Igaku · doi:10.2974/kmj1951.30.4_211 · Cited by 1
Common Gene Variants in Schizophrenia Susceptibility with Focus on Neurodevelopment
Kähler, A. K. (2009) · NORA - Norwegian Open Research Archives · Cited by 1
Pathophysiology of schizophrenia: dopamine hypothesis
Neylan, T. C. (1996) · Journal of Neuropsychiatry · doi:10.1176/jnp.8.2.222 · Cited by 1
A Critical Assessment of Antipsychotic Drug Monitoring
Waraska, J., & Nagle, J. D. (1987) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30754-6 · Cited by 1
Ligands for the dopamine D2-like receptors
van Vliet, A., & Alexander, L. C. (1998) · Cited by 1
Neural mechanisms of MK-801 induced sensitisation
Lefevre, E. M. (2016) · The University of Queensland · doi:10.14264/uql.2016.911 · Cited by 1
The use of adjuvant L-arginine in schizophrenia: A behavioural and neurochemical analysis
MacKay, M.-A. B. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3zs2kq4m · Cited by 1
Evaluating Novel Muscarinic Acetylcholine Receptor Potentiators for the Treatment of Cognitive Deficits in Schizophrenia
Grannan, M. D. (2016) · Cited by 1
Pharmacology
Bortolozzi, A. A., Díaz-Mataix, L., & Artigas, F. (2007) · Wiley eBooks · doi:10.1002/9783527619337.ch8 · Cited by 1
Antipsychotic Agents
Ablordeppey, S. Y., & Ofori, E. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc103.pub3 · Cited by 1
Antipsychotic Agents
Brown, J. M., Li, J. J., & Sinz, M. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc103.pub2 · Cited by 1
PSYCHOPHARMACOLOGICAL IMPLICATIONS OF DOPAMINE AND DOPAMINE ANTAGONISTS: A CRITICAL EVALUATION OF CURRENT EVIDENCE
Hornykiewicz, O. (1980) · Elsevier eBooks · doi:10.1016/b978-0-08-025501-9.50026-0 · Cited by 1
Investigating Extended Linker Analogues of Risperidone for Treatment of Multiple Sclerosis
Bird, T. D. (2020) · doi:10.26686/wgtn.17147636.v1 · Cited by 1
Lipogenic effects of antipsychotic drugs in cultured cells and in rat
Fernø, J. (2007) · NORA - Norwegian Open Research Archives
Neurodevelopmental animal models of schizophrenia-like behaviours: Behavioural and neurochemical consequences of maternal immune challenge and prenatal NMDA receptor blockade
Gallant, S. (2014) · Spectrum Research Repository (Concordia University)
Ventral Tegmental Area Neuronal Ensembles Accurately Encode Action Number
Wood, J. T. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
Advancing rodent models of the behaviours and the neurobiological pathology associated with schizophrenia
Madularu, D. (2014) · Spectrum Research Repository (Concordia University)
Chapter 5: Biological Factors in Psychiatric Disorders
Murphy, D. L. (1976) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61388-3
Novel pharmacological treatment alternatives for schizophrenia
Wiker, C. (2007) · Figshare
Progress in Psychopharmacotherapy though Molecular Imaging
Vernaleken, I., Gruender, G., & Cumming, P. D. (2010) · Wiley eBooks · doi:10.1002/9783527630271.ch9
COMPARTMENTALIZED D2-DOPAMINE RECEPTORS: ROLES IN SIGNALING & POTENTIAL MECHANISM OF ANTIPSYCHOTIC DRUG ACTION
Octeau, J. C. (2014) · doi:10.23860/diss-octeau-j.-2014
Effects of antipsychotic drugs on the expression of neurotransmitter receptors in the rat brain
Han, M. (2010) · Research Online (University of Wollongong)
Current Pharmacological Targets
Kelly, J. R. (2009) · doi:10.1002/9780470682920.ch4
Efectos de los antagonistas NMDA sobre la neurotransmisión serotonérgica y glutamatérgica en la corteza prefrontal. Mecanismo de acción de los fármacos antipsicóticos
Gil, J. L. (2009) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Comparing tolerability profile of second generation antipsychotics in schizophrenia and affective disorders : a meta-analysis
Moteshafi, H. (2011) · doi:10.71781/27694
The prefrontal cortex and information processing : nitric oxide signaling studied in an animal model of schizophrenia
Fejgin, K. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Postmortem Brain Studies: Focus on Susceptibility Genes in Schizophrenia
Mathew, S., Mitkus, S. N., Lipska, B. K., Hyde, T. M., & Kleinman, J. E. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn032
PHENOTHIAZINES INDUCE ABORTIVE AUTOPHAGY LEADING TO CANCER CELL DEATH
Charles, C. T. (2012) · Digital Commons-TMC (Texas Medical Center)
Eficácia de antipsicóticos atípicos comparados à clozapina em pacientes com esquizofrenia refratária: revisão sistemática e metanálise
Souza, J. D. S. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2010.tde-04112010-160946
Introductory and Basic Aspects
Artigas, F. (2007) · Wiley eBooks · doi:10.1002/9783527619337.ch6
Distribuição de receptores ionotrópicos de glutamato e sua co-localização com a fosfoproteína neural DARPP-32 no córtex pré-frontal de ratos.
Sambé, N. A. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2009.tde-22012010-100738
Störungen der Neurotransmission assoziiert mit neurologischen und psychiatrischen Syndromen
Brune, G. G., & Richter, H. (1978) · Springer eBooks · doi:10.1007/978-3-662-00937-6_11
Glutamatergic mechanisms in schizophrenia : Role of endogenous kynurenic acid
Nilsson, L. K. (2005) · Figshare
Assessment of Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs using Brain Microdialysis
Sood, P. (2010) · Figshare
Adaptations neuronales dans les maladies psychiatriques associées à une hyperdopaminergie
Rawas, R. E. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
A biological concept for diagnosis, treatment and therapy control of endogenous psychoses
Bergener, M., & Hesse, C. (1980) · Neurosurgical Review · doi:10.1007/bf01650030
“Pharmacologic studies in animals and organ preparations as in patients with mental disorders suggest disturbances in synthesis and metabolism of neurotransmitters as one important cause among others for the manifestation of endogenous psychoses (1, 9, 11, 12).”
Background
Strukturelle Analyse von Phenothiazin‐Derivaten als allosterische Inhibitoren der MALT1‐Paracaspase
Schlauderer, F., Lammens, K., Nagel, D., Vincendeau, M., Eitelhuber, A. C., Verhelst, S. H. L., Kling, D., Chruściel, A., Ruland, J., Krappmann, D., et al. (2013) · Angewandte Chemie · doi:10.1002/ange.201304290
The noneffect of lesions of the corpus striatum upon amphetamine-induced stereotypy
Wells, M. J., & Cole, S. O. (1979) · Bulletin of the Psychonomic Society · doi:10.3758/bf03329493
Electron microscopic alterations in noradrenaline nerve terminals in vas deferens of the rat following chronic administration of reserpine and chlorpromazine.
Kashiba, A., Hashimoto, H., & Kimura, H. (1983) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.16.207
Pathogenesis of schizophrenia: Loss of function of presynaptic inhibitory receptor sites
Schnieden, H. (1977) · Medical Hypotheses · doi:10.1016/0306-9877(77)90007-x
The effect of chronic chlorpromazine administration on monoamine levels in various regions of rat brain
Baf, M. H. M., Subhash, M. N., Lakshmana, K. M., & Rao, B. S. S. R. (1995) · Neurochemical Research · doi:10.1007/bf00995152
Effects of Benzamide Derivatives on Dopamine Release from Striatal Slices of Rats.
Yamada, S., Yokoo, H., & Nishi, S. (1993) · The Kurume Medical Journal · doi:10.2739/kurumemedj.40.243
“…of almost all neuroleptics inhibit electrically evoked dopamine (DA) release from striatal slices in vitro (Dismukes and Mulder, 1977; Yamada et al. 1991) and the potency for inhibition of evoked DA release correlated well with the daily dosages for clinical use (Seeman and Lee, 1975).”
Background
Chlorpromazine causes vesicle population changes in the monoaminergic synapse of the rat caudate nucleus
Kaiya, H., Iwata, T., Ikeda, K., & Namba, M. (1978) · Cellular and Molecular Life Sciences · doi:10.1007/bf01937012
Differential modulation of mouse brain biogenic amines by haloperidol and pimozide: implications in tourette's syndrome
Messiha, F. S. (1990) · Comparative Biochemistry and Physiology Part C Comparative Pharmacology · doi:10.1016/0742-8413(90)90169-a
Neurochemical aspects of the search for modern psychotropic drugs and the mechanism of their action
Mashkovskii, M. D. (1976) · Pharmaceutical Chemistry Journal · doi:10.1007/bf00758026
Non-specific neuroleptic isomer effect on calmodulin-stimulated calcium transport in erythrocyte membrane
Houston, J. P., Javors, M. A., & Bowden, C. L. (1985) · Neurochemistry International · doi:10.1016/0197-0186(85)90029-4
CSF Monoamine Metabolism in Patients with Tardive Dyskinesia: Effect of Oxypertine and Hydroxyzine Pamoate
Akiyama, K., Nagao, T., Yamamoto, M., Fujimoto, A., Ebara, T., Sato, M., & Otsuki, S. (1983) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1983.tb00312.x
The phencyclidine model of schizophrenia : dysregulation of brain dopamine systems induced by NMDA receptor antagonists
Mathé, J. M. (1998) · Figshare
Selective Review of Proton Magnetic Resonance Spectroscopy in Schizophrenia
Rao, N. P. (2014) · NOT FOUND REPOSITORY (Indian Institute of Science Bangalore)
Endogenous kynurenic acid and schizophrenia : Physiological and pharmacological aspects
Schwieler, L. (2006) · Figshare
The kynurenine pathway and development of schizophrenia : Immunological and genetic aspects
Holtze, M. (2011)
Role of the endocannabinoid system in human brain functions relevant for psychiatric disorders
Bossong, M. G. (2008) · Utrecht University Repository (Utrecht University)
POST-WEANING SOCIAL ISOLATION AND SUBCHRONIC NMDA GLUTAMATE RECEPTOR BLOCKADE: EFFECTS ON LOCOMOTOR ACTIVITY AND GABA SIGNALLING IN THE RAT
Hickey, A. J. (2010) · QSpace (Queen's University Library)
IDENTIFICACIÓN DE FACTORES GENÉTICOS EN LA ETIOLOGÍA DE LA ESQUIZOFRENIA Identification of Genetic Factors in the Etiology of Schizophrenia
Aguilar‐Valles, A. (2011) · Repositorio Institucional UN - Biblioteca Digital
An investigation into the amphetamine model of psychosis in healthy volunteers
Albrecht, M. A. (2012) · UWA Profiles and Research Repository (UWA)
The role of insulin and Akt in the regulation of the norepinephrine transporter and monoamine homeostasis
Robertson, S. D. (2010)
Comprehensive genetic association analysis of genes from the Reelin and DISC1 networks in schizophrenia and neurocognitive endophenotypes
Bouwer, S. (2010) · UWA Profiles and Research Repository (University of Western Australia)
Dopamintransporters im Gehirn bei gesunden Kontrollen, Patienten mit schizophrenen Störungen und Patienten mit Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörungen
la Fougère, C. (2003)
Determinanten für den Ein- und Ausschluss von Patienten bei Phase III- und IV-Studien an einer psychiatrisch-psychotherapeutischen Versorgungsklinik
München, L.-M.-U. (2009)
The Differential Contribution of Striatonigral and Striatopallidal Neurons in Mediating Responses to Therapeutic Agents and Drugs of Abuse: A Dual Role for DARPP-32
Bateup, H. S. (2025) · Digital Commons - RU (Rockefeller University) · doi:10.48496/p78x-kb92
GSK3 Networks in Schizophrenia
Khlghatyan, J., Fakhfouri, G., & Beaulieu, J. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622499-00173
POSSIBLE RELEVANCE FOR SCHIZOPHRENIA
Mattsson, A. (2005)
Structural and Systems Approach to Central Representation of Motor Functions: Importance of State Dependent Reactions
Jasper, H. H. (1975) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100020412
A Comparison of Pimozide and Haloperidol in the Treatment of
Ross, M. S., & Moldofsky, H. (1978)
[PET (positron emission tomography) research on schizophrenia].
Takano, A., & Suhara, T. (2006) · Folia Pharmacologica Japonica · doi:10.1254/fpj.128.177
Dimensions of GSK3 Monoamine-Related Intracellular Signaling in Schizophrenia
Fakhfouri, G., Khlghatyan, J., Sukhanov, I., Gainetdinov, R. R., & Beaulieu, J. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00026-2
Whole genome analysis of genetic susceptibility factors in psychotic disorders
Athanasiu, L. (2011) · NORA - Norwegian Open Research Archives
Biological Aspects of Psychoses and Their Treatment
van Praag, H. M. (1978) · doi:10.1007/978-1-349-04130-5_11

Authors: Seeman, P., & Lee, T.
Affiliations: University of Toronto (CA)
ORCID: Seeman, P.
Lee, T.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1975-06-20
Volume: 188
Issue: 4194
Pages: 1217-1219
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.1145194
OpenAlex: W2006122360
Cited by: 869
References: 35
Citations by year: 2026: 5 · 2025: 8 · 2024: 13 · 2023: 16 · 2022: 22 · 2021: 13 · 2020: 18 · 2019: 36 · 2018: 21 · 2017: 30 · 2016: 26 · 2015: 28 · 2014: 37 · 2013: 23 · 2012: 32
FWCI: 62.55
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: antipsychotic drugs, presynaptic dopamine release, striatum, spiperone, thioridazine, butyrophenones, phenothiazines, reserpine, pimozide, clozapine, butaclamol, stereoisomers, acetylcholine release, GABA release, schizophrenia
MeSH terms: Acetylcholine, Animals, Corpus Striatum, Dopamine, Dose-Response Relationship, Drug, Electric Stimulation, gamma-Aminobutyric Acid, Haloperidol, Humans, Male, Neurons, Neurosecretion, Schizophrenia, Tranquilizing Agents, Tritium, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks